Integer Holdings Corporation (ITGR)
NYSE: ITGR · Real-Time Price · USD
142.22
-1.29 (-0.90%)
Jan 31, 2025, 4:00 PM EST - Market closed
Integer Holdings Revenue
Integer Holdings had revenue of $431.42M in the quarter ending September 27, 2024, with 8.72% growth. This brings the company's revenue in the last twelve months to $1.71B, up 12.41% year-over-year. In the year 2023, Integer Holdings had annual revenue of $1.60B with 16.03% growth.
Revenue (ttm)
$1.71B
Revenue Growth
+12.41%
P/S Ratio
2.78
Revenue / Employee
$163,107
Employees
10,500
Market Cap
4.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1.60B | 220.58M | 16.03% |
| Dec 31, 2022 | 1.38B | 155.02M | 12.70% |
| Dec 31, 2021 | 1.22B | 147.64M | 13.75% |
| Dec 31, 2020 | 1.07B | -184.65M | -14.68% |
| Dec 31, 2019 | 1.26B | 43.08M | 3.55% |
| Dec 28, 2018 | Pro | Pro | Pro |
| Dec 29, 2017 | Pro | Pro | Pro |
| Dec 30, 2016 | Pro | Pro | Pro |
| Jan 1, 2016 | Pro | Pro | Pro |
| Jan 2, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 63.17B |
| AbbVie | 55.53B |
| Novartis AG | 51.72B |
| AstraZeneca | 51.21B |
| Thermo Fisher Scientific | 42.88B |
| Abbott Laboratories | 41.95B |
ITGR News
- 4 days ago - Integer to Highlight Innovations in Neuromodulation, Next Generation of Miniaturized Active Implantable Devices During NANS 2025 Annual Meeting - GlobeNewsWire
- 23 days ago - The Best Growth Stocks to Buy - Kiplinger
- 4 weeks ago - Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028 - GlobeNewsWire
- 2 months ago - Integer to Present at Piper Sandler Healthcare Conference on Dec. 3, 2024 - GlobeNewsWire
- 3 months ago - Integer Holdings Corporation Completes Divestiture of Non-Medical Business for $50 Million - GlobeNewsWire
- 3 months ago - Integer Holdings Corporation (ITGR) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Integer to Present at the 2024 Wells Fargo Healthcare Conference - GlobeNewsWire
- 6 months ago - Integer Holdings Releases Inaugural Impact Report - GlobeNewsWire